Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92,315,749
-
Total 13F shares
-
91,815,449
-
Share change
-
-134,974
-
Total reported value
-
$7,311,195,962
-
Put/Call ratio
-
108%
-
Price per share
-
$79.64
-
Number of holders
-
273
-
Value change
-
-$2,122,799
-
Number of buys
-
109
-
Number of sells
-
165
Institutional Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q2 2023
As of 30 Jun 2023 Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) had 273 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 91,815,449 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, DIMENSIONAL FUND ADVISORS LP, JPMORGAN CHASE & CO, Invesco Ltd., VIKING GLOBAL INVESTORS LP, and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC.
This table shows 276 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.